PrecisionBiotics

What PrecisionBiotics does

PrecisionBiotics Group Ltd. is an Ireland-based consumer health company that develops and sells precision probiotic supplements built around proprietary, clinically validated bacterial strains (notably Bifidobacterium 35624 and 1714) selected for specific gut-health actions rather than multi-strain blends. Its product portfolio spans the Alflorex® franchise (Original, Chewable, Children, Dual Action, Immune variants) for digestive and immune health, the Zenflore® franchise (Teen and Calm variants) targeting the gut-brain axis for stress and sleep support, plus Daily Good Bacteria and Women's Flora. The company is a wholly-owned subsidiary of the Danish biosolutions group Novonesis (formerly Novozymes), operating from Cork, Ireland, with products sold across more than 15 countries through a strategic partnership with Biocodex, complemented by direct-to-consumer e-commerce and Irish pharmacy distribution.

The business model is direct-to-consumer and pharmacy-led retail: revenue is generated through one-time product sales of clinically positioned supplements, with pharmacist endorsement (evidenced by a decade of IPN OTC Awards recognition) serving as a key credibility and conversion lever. Product pricing is not publicly disclosed. Marketing relies on scientific content (Health Hub, gut-insights articles, expert podcasts), broad social media presence, email capture, and a dedicated healthcare-professional portal. The strategic posture in 2026 reflects measured expansion: new SKU launches into adjacent segments (pediatric, adolescent, stress/sleep), a renewed long-term partnership with Biocodex to deepen international reach, and sustained award-driven brand reinforcement in the Irish pharmacy channel.

Name

PrecisionBiotics

Legal name

PrecisionBiotics Group Ltd.

Website

https://precisionbiotics.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

1–10 employees

Short description

PrecisionBiotics is an Ireland-based probiotic supplement company and Novonesis subsidiary that sells clinically validated, precision bacterial strain products (Alflorex, Zenflore) to consumers via e-commerce, pharmacies, and a Biocodex-led international distribution network across 15+ countries.

Ownership category

akta.pro rank

Product category

Probiotic Supplements

NAICS

Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Probiotics & Digestive Health Supplements (CRADAGAF)

Keywords

• Probiotic supplements
• Gut health products
• Microbiome science
• Digestive health
• Clinically validated probiotics

Headquarters

HQ city

Cork

HQ country

Ireland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Marketing or Sales, Technology or R&D, Operations, Personnel

Revenue model

1. Direct-to-Consumer Probiotic Sales: PrecisionBiotics generates revenue through direct sales of its precision probiotic supplements (Alflorex, Zenflore, Daily Good Bacteria, Women's Flora) via its e-commerce storefront and retail/pharmacy channels. Products are sold as consumer health supplements with a focus on specific gut health outcomes.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

PrecisionBiotics develops, manufactures, and sells clinically validated probiotic dietary supplements built around 1-2 precision-selected bacterial strains per product. The flagship offering is the Alflorex® line, led by a proprietary Bifidobacterium 35624 culture validated through human clinical trials in the UK and Europe, with additional product families (Zenflore®, Women's Flora, Daily Good Bacteria, Alflorex Children) targeting gut-brain, intimate health, pediatric, and general digestive wellness segments.

Product overview

PrecisionBiotics is a probiotic health company offering a portfolio of precision probiotic supplements based on microbiome science. The core product is Alflorex®, containing the proprietary Bifidobacterium 35624® culture, which is supported by clinical trials conducted in the UK and Europe. The product range includes Alflorex® variants (Original, Chewable, Children, Dual Action, Immune) addressing different consumer needs from pediatric to immune support. The Zenflore® line targets the gut-brain axis with formulations for teens (Zenflore® Teen) and stress relief (Zenflore® Calm). Additional products include Daily Good Bacteria for general maintenance and Women's Flora for feminine health. The company emphasizes precision bacterial cultures (1-2 types rather than multiple strains), clinically tested formulations that require no refrigeration, and free-from attributes including soy-free, gluten-free, dairy-free, and lactose-free. PrecisionBiotics is part of Novonesis and maintains a strategic partnership with Biocodex spanning nine years, with products available in over 15 countries.

Differentiator

Problem solved

Functional benefit

Brands

• Alflorex®: Flagship probiotic product for gut health, available in multiple formats including original, chewable, children, dual action, and immune variants.
• Zenflore®
• PrecisionBiotic®

Products and services

• Alflorex® (Original) Flagship probiotic supplement containing the precision bacterial culture Bifidobacterium 35624, clinically tested in UK and Europe for digestive health. Targeted at adults seeking gut health support; distributed in over 15 countries.
• Alflorex® Chewable Chewable tablet format of the Alflorex probiotic providing the same 35624 culture in a portable, on-the-go format. Targeted at adults who prefer not to swallow capsules.
• Alflorex® Children Pediatric probiotic formulation designed specifically for children's digestive and gut health needs. Targeted at parents seeking daily probiotic support for children.
• Alflorex® Dual Action Enhanced dual-action formula combining the Alflorex 35624 culture with additional prebiotic fiber for comprehensive gut support. Targeted at adults seeking combined probiotic and prebiotic action.
• Alflorex® Immune Formulation combining gut health benefits with targeted immune system support. Targeted at adults seeking combined digestive and immune wellness.
• Daily Good Bacteria Daily probiotic supplement providing general gut health support with precision bacterial cultures. Targeted at consumers seeking everyday maintenance of microbiome balance.
• Women's Flora Probiotic supplement formulated specifically for women's vaginal and urinary tract health support. Targeted at women seeking intimate wellness through microbiome balance.
• Zenflore® Teen Probiotic designed for teenagers, supporting the gut-brain axis and stress management during adolescence. Targeted at adolescents and parents of teens seeking natural stress and mood support.
• Zenflore® Calm Calm and stress support probiotic targeting the gut-brain connection for mood and mental wellness. Targeted at adults experiencing stress, sleep anxiety, or difficulty relaxing.

Quantifiable outcome

• Products available in over 15 countries
• +1 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• BiocodexcoreStrategic or Co-development Partner · 23 April 2026Nine-year strategic partnership formalized with new agreement in 2026, focused on microbiome science and consumer health. The partnership expands scientific collaboration and market reach for flagship product Alflorex, now available in over 15 countries. The agreement is expected to accelerate growth by deepening scientific collaboration and unlocking new market opportunities through Biocodex's distribution network.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Bio-Kult: UK probiotic supplement brand owned by ADM that competes in the same clinically backed, pharmacy-recommended gut health category as Alflorex, with overlapping consumer targeting around digestive wellness.
• Garden of Life: Premium whole-food and probiotic supplement brand (Nestlé Health Science) competing in the same evidence-led, multi-condition digestive health positioning with strong DTC and natural-channel distribution.
• Renew Life: US-focused probiotic and digestive wellness supplement brand with a similar clinically validated, multi-condition SKU portfolio covering gut, women's, and immune health.
• Optibac Probiotics: UK-based DTC probiotic brand with a comparable precision/clinical positioning, single- and multi-strain SKUs targeting gut, women's, and baby health, and a similar reliance on human clinical trial evidence to differentiate from generic probiotics.
• NOW Foods: Large US-based supplements manufacturer with an extensive probiotic SKU portfolio spanning single- and multi-strain products at competitive price points, competing for the same value-conscious health-supplement shopper.
• Vivomixx (Mendes SA): High-dose, clinically validated multi-strain probiotic brand distributed across European pharmacies and prescribed by gastroenterologists, directly competing with Alflorex in the IBS and gut-health prescriber channel.
• Culturelle: Global single-strain probiotic brand (Lactobacillus rhamnosus GG) owned by DSM/d'sm-firmenich; mirrors PrecisionBiotics' precision-strain strategy and competes for the same clinically minded consumer across digestive and immunity use cases.

Broad incumbents

• Yakult Honsha: Global incumbent in probiotic dairy drinks (Lactobacillus casei Shirota) with massive brand awareness; overlaps with PrecisionBiotics on consumer gut-health demand but competes via a dairy delivery format rather than supplements.
• Danone (Actimel / Activia): Multinational food giant whose Actimel and Activia probiotic dairy ranges compete for the same mass-market gut-health consumer as PrecisionBiotics, but at lower price points and via grocery rather than pharmacy channels.

Others

• Biocodex: French specialty pharma company that is simultaneously PrecisionBiotics' international distribution partner for Alflorex and a direct competitor through its own probiotic brands (Ultralevura/Saccharomyces boulardii) in adjacent indications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xtwitter.com/AHealthIrl
• YouTubeyoutube.com/@precisionbiotics
• Facebookfacebook.com/PrecisionBioticsIreland
• LinkedInlinkedin.com/company/precisionbiotics
• Instagraminstagram.com/precisionbioticsireland

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PrecisionBiotics